Molecular Biological. Quantitative Analysis and Biostatistical Core The goals of the Core are: (1) to provide the technology, personnel and technical expertise necessary to successfully complete the experiments proposed in this Center;(2) to provide the mechanism for the initiation of """"""""pilot projects"""""""" which take advantage of the combined experience in this core to explore new and novel, and possibly """"""""high risk"""""""", avenues of research;(3) to provide training to Center personnel and outside scientists (at all levels) in the use of our specialized techniques. This Core is designed to be an integrated molecular biology, molecular genetics and quantitative analysis resource that will coordinate, conduct, and support the research activities of this proposal The Molecular Biological, Quantitative Analysis and Biostatistical Core resource is staffed by researchers who have extensive experience in diverse techniques in molecular biology and who have expertise in the development of novel techniques and approaches to technical problems. The Molecular Biological, Quantitative Analysis and Biostatistical Core interacts extensively with Projects 1, 2 and 4 of this Central grant proposal. This Core will work interactively with the other Cores described in this proposal, with scientific research services available at The Rockefeller University and surrounding institutions, and synergize with other projects conducted by researchers in the laboratory of The Principal Investigator.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Comprehensive Center (P60)
Project #
5P60DA005130-24
Application #
8075620
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
24
Fiscal Year
2010
Total Cost
$593,456
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Gasser, Paul J; Hurley, Matthew M; Chan, June et al. (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913-1928
Butelman, Eduardo Roque; Bacciardi, Silvia; Maremmani, Angelo Giovanni Icro et al. (2017) Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity? Am J Addict 26:632-639
Valenza, Marta; Picetti, Roberto; Yuferov, Vadim et al. (2016) Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration. Neuropharmacology 105:639-650
Garzón, Miguel; Pickel, Virginia M (2016) Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum. J Comp Neurol 524:3084-103
Zhou, Yan; Leri, Francesco; Cummins, Erin et al. (2015) Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol Behav 139:127-35
Zhou, Y; Kreek, M J (2015) Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic ""binge"" pattern escalating-dose, but not steady-dose, cocaine. Neuroscience 289:63-70
Zhou, Yan; Kreek, Mary Jeanne (2014) Alcohol: a stimulant activating brain stress responsive systems with persistent neuroadaptation. Neuropharmacology 87:51-8
Mayer-Blackwell, B; Schlussman, S D; Butelman, E R et al. (2014) Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression. Neuroscience 258:280-91
Garzón, Miguel; Pickel, Virginia M (2013) Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission. J Comp Neurol 521:2927-46
Levran, Orna; Peles, Einat; Randesi, Matthew et al. (2013) Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics 14:755-68

Showing the most recent 10 out of 168 publications